Preclinical models for drug discovery for metastatic disease

[1]  I. Larionova,et al.  Technologies for Viable Circulating Tumor Cell Isolation , 2022, International journal of molecular sciences.

[2]  K. Pantel,et al.  Crucial roles of circulating tumor cells in the metastatic cascade and tumor immune escape: biology and clinical translation , 2022, Journal for ImmunoTherapy of Cancer.

[3]  K. Tanner,et al.  Biophysical determinants of cancer organotropism. , 2022, Trends in cancer.

[4]  H. Munshi,et al.  The difficulty in translating the preclinical success of combined TGFβ and immune checkpoint inhibition to clinical trial , 2022, EBioMedicine.

[5]  J. Condeelis,et al.  Intravital imaging to study cancer progression and metastasis , 2022, Nature reviews. Cancer.

[6]  P. Campbell,et al.  Spatial genomics maps the structure, nature and evolution of cancer clones , 2022, Nature.

[7]  J. Elstrott,et al.  LRRC15+ myofibroblasts dictate the stromal setpoint to suppress tumour immunity , 2022, Nature.

[8]  L. Trusolino,et al.  Towards precision oncology with patient-derived xenografts , 2022, Nature Reviews Clinical Oncology.

[9]  S. Naik,et al.  Mastering the use of cellular barcoding to explore cancer heterogeneity , 2022, Nature Reviews Cancer.

[10]  Takeshi Imamura,et al.  Cell–matrix interface regulates dormancy in human colon cancer stem cells , 2022, Nature.

[11]  N. Hacohen,et al.  In vivo CRISPR screens reveal the landscape of immune evasion pathways across cancer , 2022, Nature Immunology.

[12]  R. Harman,et al.  Induced mammary cancer in rat models: pathogenesis, genetics, and relevance to female breast cancer , 2022, Journal of Mammary Gland Biology and Neoplasia.

[13]  R. Jain,et al.  The local microenvironment matters in preclinical basic and translational studies of cancer immunology and immunotherapy. , 2022, Cancer cell.

[14]  K. Pantel,et al.  Detection and Characterization of Estrogen Receptor α Expression of Circulating Tumor Cells as a Prognostic Marker , 2022, Cancers.

[15]  Luis Enrique Cortés-Hernández,et al.  Functional analysis of circulating tumour cells: the KEY to understand the biology of the metastatic cascade , 2022, British Journal of Cancer.

[16]  J. Burks,et al.  Cutting-Edge Platforms for Analysis of Immune Cells in the Hepatic Microenvironment—Focus on Tumor-Associated Macrophages in Hepatocellular Carcinoma , 2022, Cancers.

[17]  Eun Sug Park,et al.  Spatial CRISPR genomics identifies regulators of the tumor microenvironment , 2022, Cell.

[18]  R. Goldszmid,et al.  Recognition of observer effect is required for rigor and reproducibility of preclinical animal studies. , 2022, Cancer cell.

[19]  D. Hanahan.  Hallmarks of Cancer: New Dimensions. , 2022, Cancer discovery.

[20]  D. Esposito,et al.  Live tumor imaging shows macrophage induction and TMEM-mediated enrichment of cancer stem cells during metastatic dissemination , 2021, Nature Communications.

[21]  G. Ghanem,et al.  Humanized Mice as a Valuable Pre-Clinical Model for Cancer Immunotherapy Research , 2021, Frontiers in Oncology.

[22]  Cyrus M. Ghajar,et al.  Elimination of fluorescent protein immunogenicity permits modeling of metastasis in immune-competent settings. , 2021, Cancer cell.

[23]  I. Sack,et al.  Microscopic multifrequency MR elastography for mapping viscoelasticity in zebrafish , 2021, Magnetic resonance in medicine.

[24]  M. Denvir,et al.  PET/CT Technology in Adult Zebrafish: A Pilot Study Toward Live Longitudinal Imaging , 2021, Frontiers in Medicine.

[25]  H. Schreiber,et al.  Criteria to make animal studies more relevant to treating human cancer. , 2021, Current opinion in immunology.

[26]  T. Libermann,et al.  Emerging Evidence of the Gut Microbiome in Chemotherapy: A Clinical Review , 2021, Frontiers in Oncology.

[27]  Hae-Chul Park,et al.  Transgenic fluorescent zebrafish lines that have revolutionized biomedical research , 2021, Laboratory animal research.

[28]  C. Isaacs,et al.  Circulating Tumor Cells: Technologies and Their Clinical Potential in Cancer Metastasis , 2021, Biomedicines.

[29]  Kevin J. Cheung,et al.  Collective metastasis: coordinating the multicellular voyage , 2021, Clinical & Experimental Metastasis.

[30]  A. Broeks,et al.  An ex vivo tumor fragment platform to dissect response to PD-1 blockade in cancer , 2021, Nature Medicine.

[31]  L. Zon,et al.  Zebrafish disease models in drug discovery: from preclinical modelling to clinical trials , 2021, Nature Reviews Drug Discovery.

[32]  Beth K. Martin,et al.  Single-cell lineage tracing of metastatic cancer reveals selection of hybrid EMT states. , 2021, Cancer cell.

[33]  F. di Costanzo,et al.  Circulating tumour cells and cell-free DNA as a prognostic factor in metastatic colorectal cancer: the OMITERC prospective study , 2021, British Journal of Cancer.

[34]  J. Cueva,et al.  Short-Term Ex Vivo Culture of CTCs from Advance Breast Cancer Patients: Clinical Implications , 2021, Cancers.

[35]  J. Joyce,et al.  Therapeutic Targeting of the Tumor Microenvironment. , 2021, Cancer discovery.

[36]  L. Zon,et al.  Melanoma models for the next generation of therapies. , 2021, Cancer cell.

[37]  D. Adams,et al.  The use of CRISPR/Cas9-based gene editing strategies to explore cancer gene function in mice. , 2021, Current opinion in genetics & development.

[38]  T. Rebbeck,et al.  Improved Prognostic Stratification Using Circulating Tumor Cell Clusters in Patients with Metastatic Castration-Resistant Prostate Cancer , 2021, Cancers.

[39]  In-Hwan Kim,et al.  Detection of Circulating Gastrointestinal Cancer Cells in Conditionally Reprogrammed Cell Culture , 2021, In Vivo.

[40]  D. Pe’er,et al.  Frontiers in cancer immunotherapy—a symposium report , 2020, Annals of the New York Academy of Sciences.

[41]  Kelly P. Stanton,et al.  Efficient Propagation of Circulating Tumor Cells: A First Step for Probing Tumor Metastasis , 2020, Cancers.

[42]  M. Lutolf,et al.  Recapitulating macro-scale tissue self-organization through organoid bioprinting , 2020, Nature Materials.

[43]  P. Janmey,et al.  Effects of extracellular matrix viscoelasticity on cellular behaviour , 2020, Nature.

[44]  F. Castro-Giner,et al.  Circulating tumor cells: Ready for translation? , 2020, The Journal of experimental medicine.

[45]  J. Condeelis,et al.  The role of the tumor microenvironment in tumor cell intravasation and dissemination. , 2020, European journal of cell biology.

[46]  S. Manalis,et al.  YAP Enhances Tumor Cell Dissemination by Promoting Intravascular Motility and Reentry into Systemic Circulation , 2020, Cancer Research.

[47]  C. June,et al.  A rational mouse model to detect on-target off-tumor CAR T cell toxicity. , 2020, JCI insight.

[48]  S. Cairo,et al.  Genetic characterization of a unique neuroendocrine transdifferentiation prostate circulating tumor cell-derived eXplant model , 2020, Nature Communications.

[49]  L. Zon,et al.  Zebrafish patient avatars in cancer biology and precision cancer therapy , 2020, Nature Reviews Cancer.

[50]  T. Lawrence,et al.  Expansion of Circulating Tumor Cells from Patients with Locally Advanced Pancreatic Cancer Enable Patient Derived Xenografts and Functional Studies for Personalized Medicine , 2020, Cancers.

[51]  A. Sieuwerts,et al.  Plasticity of Lgr5-Negative Cancer Cells Drives Metastasis in Colorectal Cancer , 2020, Cell stem cell.

[52]  Stacey D. Finley,et al.  Modeling immune cell behavior across scales in cancer , 2020, Wiley interdisciplinary reviews. Systems biology and medicine.

[53]  N. Aceto.  Bring along your friends: Homotypic and heterotypic circulating tumor cell clustering to accelerate metastasis , 2020, Biomedical journal.

[54]  Maxwell P. Lee,et al.  Metastasis-Specific Gene Expression in Autochthonous and Allograft Mouse Mammary Tumor Models: Stratification and Identification of Targetable Signatures , 2019, Molecular Cancer Research.

[55]  Chi-Ping Day,et al.  Multi-model preclinical platform predicts clinical response of melanoma to immunotherapy , 2019, bioRxiv.

[56]  A. Weeraratna,et al.  How the ageing microenvironment influences tumour progression , 2019, Nature Reviews Cancer.

[57]  A. Seyhan.  Lost in translation: the valley of death across preclinical and clinical divide – identification of problems and overcoming obstacles , 2019, Translational Medicine Communications.

[58]  E. D. de Vries,et al.  A review of bispecific antibodies and antibody constructs in oncology and clinical challenges. , 2019, Pharmacology & therapeutics.

[59]  Laura Keller,et al.  Unravelling tumour heterogeneity by single-cell profiling of circulating tumour cells , 2019, Nature Reviews Cancer.

[60]  D. Langenau,et al.  Adult immune compromised zebrafish for xenograft cell transplantation studies , 2019, EBioMedicine.

[61]  N. Morgan,et al.  Tissue Architectural Cues Drive Organ Targeting of Tumor Cells in Zebrafish. , 2019, Cell systems.

[62]  E. Chesler,et al.  High-Diversity Mouse Populations for Complex Traits. , 2019, Trends in genetics : TIG.

[63]  J. D'haese,et al.  Advances in cancer immunotherapy 2019 – latest trends , 2019, Journal of experimental & clinical cancer research : CR.

[64]  J. Fletcher,et al.  Visualizing Engrafted Human Cancer and Therapy Responses in Immunodeficient Zebrafish , 2019, Cell.

[65]  Amit Singh,et al.  Hippo Signaling in Cancer: Lessons From Drosophila Models , 2019, Front. Cell Dev. Biol..

[66]  Hermann B. Frieboes,et al.  Mathematical modeling of tumor-immune cell interactions. , 2019, Journal of theoretical biology.

[67]  Jeffrey T. Chang,et al.  Resistance to neoadjuvant chemotherapy in triple-negative breast cancer mediated by a reversible drug-tolerant state , 2019, Science Translational Medicine.

[68]  T. Hoshiba.  Decellularized Extracellular Matrix for Cancer Research , 2019, Materials.

[69]  D. Grifoni,et al.  Drosophila melanogaster: A Model Organism to Study Cancer , 2019, Front. Genet..

[70]  T. Fehm,et al.  The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper. , 2019, Critical reviews in oncology/hematology.

[71]  D. Ingber,et al.  Modelling cancer in microfluidic human organs-on-chips , 2019, Nature Reviews Cancer.

[72]  I. Abdulkader,et al.  CTCs‐derived xenograft development in a triple negative breast cancer case , 2018, International journal of cancer.

[73]  Robert Prevedel,et al.  Imaging mechanical properties of sub-micron ECM in live zebrafish using Brillouin microscopy , 2018, bioRxiv.

[74]  Jacqueline A. Hall,et al.  A framework for the development of effective anti-metastatic agents , 2018, Nature Reviews Clinical Oncology.

[75]  A. Schneeweiss,et al.  Sustained prognostic impact of circulating tumor cell status and kinetics upon further progression of metastatic breast cancer , 2018, Breast Cancer Research and Treatment.

[76]  Jürgen Czarske,et al.  Mechanical Mapping of Spinal Cord Growth and Repair in Living Zebrafish Larvae by Brillouin Imaging , 2018, Biophysical journal.

[77]  Milica Radisic,et al.  Advances in organ-on-a-chip engineering , 2018, Nature Reviews Materials.

[78]  N. Loman,et al.  Longitudinal enumeration and cluster evaluation of circulating tumor cells improve prognostication for patients with newly diagnosed metastatic breast cancer in a prospective observational trial , 2018, Breast Cancer Research.

[79]  H. Clevers,et al.  Organoids in cancer research , 2018, Nature Reviews Cancer.

[80]  N. Paul,et al.  Hemodynamic forces tune the arrest, adhesion and extravasation of circulating tumor cells , 2017, bioRxiv.

[81]  A. Brunet,et al.  The African turquoise killifish: A research organism to study vertebrate aging and diapause , 2018, Aging cell.

[82]  K. Hunter,et al.  Genetic insights into the morass of metastatic heterogeneity , 2018, Nature Reviews Cancer.

[83]  Sabine Riethdorf,et al.  Clinical applications of the CellSearch platform in cancer patients. , 2018, Advanced drug delivery reviews.

[84]  R. Bourgon,et al.  TGF-β attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells , 2018, Nature.

[85]  L. Zon,et al.  Generation of mouse-zebrafish hematopoietic tissue chimeric embryos for hematopoiesis and host-pathogen interaction studies , 2017, Disease Models & Mechanisms.

[86]  Z. Mourelatos,et al.  High-Affinity GD2-Specific CAR T Cells Induce Fatal Encephalitis in a Preclinical Neuroblastoma Model , 2017, Cancer Immunology Research.

[87]  M. Hidalgo,et al.  Patient-derived xenografts effectively capture responses to oncology therapy in a heterogeneous cohort of patients with solid tumors , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

[88]  M. Donia,et al.  Clinical responses to adoptive T-cell transfer can be modeled in an autologous immune-humanized mouse model , 2017, Nature Communications.

[89]  R. Kaplan,et al.  KLF4-dependent perivascular cell plasticity mediates pre-metastatic niche formation and metastasis , 2017, Nature Medicine.

[90]  Qing Xu,et al.  Human macrophages survive and adopt activated genotypes in living zebrafish , 2017, bioRxiv.

[91]  T. Carvalho,et al.  Single-cell functional and chemosensitive profiling of combinatorial colorectal therapy in zebrafish xenografts , 2017, Proceedings of the National Academy of Sciences.

[92]  W. Kaelin,et al.  Common pitfalls in preclinical cancer target validation , 2017, Nature Reviews Cancer.

[93]  Gavin D. Merrifield,et al.  Rapid and recoverable in vivo magnetic resonance imaging of the adult zebrafish at 7T , 2017, Magnetic resonance imaging.

[94]  K. Tanner,et al.  In situ calibration of position detection in an optical trap for active microrheology in viscous materials. , 2017, Optics express.

[95]  R. Weinberg,et al.  Emerging Biological Principles of Metastasis , 2017, Cell.

[96]  Hans Clevers,et al.  Interrogating open issues in cancer precision medicine with patient-derived xenografts , 2017, Nature Reviews Cancer.

[97]  M. Bissell,et al.  Organoids: A historical perspective of thinking in three dimensions , 2017, The Journal of cell biology.

[98]  Rainer Spang,et al.  Early dissemination seeds metastasis in breast cancer , 2016, Nature.

[99]  J. Condeelis,et al.  Mechanism of early dissemination and metastasis in Her2+ mammary cancer , 2016, Nature.

[100]  Anthony Atala,et al.  Organoid-on-a-chip and body-on-a-chip systems for drug screening and disease modeling. , 2016, Drug discovery today.

[101]  Simak Ali,et al.  Mutation Analysis of Cell-Free DNA and Single Circulating Tumor Cells in Metastatic Breast Cancer Patients with High Circulating Tumor Cell Counts , 2016, Clinical Cancer Research.

[102]  G. Beatty,et al.  Genetically Engineered Mouse Models of Pancreatic Cancer: The KPC Model (LSL‐KrasG12D/+;LSL‐Trp53R172H/+;Pdx‐1‐Cre), Its Variants, and Their Application in Immuno‐oncology Drug Discovery , 2016, Current protocols in pharmacology.

[103]  M. Cristofanilli,et al.  Circulating Cancer-Associated Macrophage-Like Cells Differentiate Malignant Breast Cancer and Benign Breast Conditions , 2016, Cancer Epidemiology, Biomarkers & Prevention.

[104]  W. Haining,et al.  Recapitulating adult human immune traits in laboratory mice by normalizing environment , 2016, Nature.

[105]  C. Dive,et al.  Tumourigenic non-small-cell lung cancer mesenchymal circulating tumour cells: a clinical case study , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

[106]  K. Tanner,et al.  In vivo tissue has non-linear rheological behavior distinct from 3D biomimetic hydrogels, as determined by AMOTIV microscopy. , 2016, Biomaterials.

[107]  N. Dhomen,et al.  Application of Sequencing, Liquid Biopsies, and Patient-Derived Xenografts for Personalized Medicine in Melanoma. , 2016, Cancer discovery.

[108]  H. Nam,et al.  The short-lived African turquoise killifish: an emerging experimental model for ageing , 2016, Disease Models & Mechanisms.

[109]  Jiyun Kim,et al.  Independent Control of Topography for 3D Patterning of the ECM Microenvironment , 2015, Advanced materials.

[110]  Joshua M. Korn,et al.  High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response , 2015, Nature Medicine.

[111]  Mehmet Toner,et al.  En Route to Metastasis: Circulating Tumor Cell Clusters and Epithelial-to-Mesenchymal Transition. , 2015, Trends in cancer.

[112]  J. Massagué,et al.  Surviving at a Distance: Organ-Specific Metastasis. , 2015, Trends in cancer.

[113]  A. Papadimitropoulos,et al.  Bioreactor-engineered cancer tissue-like structures mimic phenotypes, gene expression profiles and drug resistance patterns observed "in vivo". , 2015, Biomaterials.

[114]  Jiyun Kim,et al.  Recapitulating the Tumor Ecosystem Along the Metastatic Cascade Using 3D Culture Models , 2015, Front. Oncol..

[115]  M. Gottesman,et al.  Beyond 3D culture models of cancer , 2015, Science Translational Medicine.

[116]  Param Priya Singh,et al.  A Platform for Rapid Exploration of Aging and Diseases in a Naturally Short-Lived Vertebrate , 2015, Cell.

[117]  D. Beebe,et al.  Microfluidic model of ductal carcinoma in situ with 3D, organotypic structure , 2015, BMC Cancer.

[118]  G. Dubini,et al.  Human 3D vascularized organotypic microfluidic assays to study breast cancer cell extravasation , 2014, Proceedings of the National Academy of Sciences.

[119]  Hans Clevers,et al.  Organoid Cultures Derived from Patients with Advanced Prostate Cancer , 2014, Cell.

[120]  Alex J Walsh,et al.  Quantitative optical imaging of primary tumor organoid metabolism predicts drug response in breast cancer. , 2014, Cancer research.

[121]  Sridhar Ramaswamy,et al.  Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility , 2014, Science.

[122]  Mahmood Ayub,et al.  Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancer , 2014, Nature Medicine.

[123]  Amber J. Giles,et al.  Disruption of CXCR2-Mediated MDSC Tumor Trafficking Enhances Anti-PD1 Efficacy , 2014, Science Translational Medicine.

[124]  A. Krešo,et al.  Evolution of the cancer stem cell model. , 2014, Cell stem cell.

[125]  M. Rugge,et al.  Retaining the long-survive capacity of Circulating Tumor Cells (CTCs) followed by xeno-transplantation: not only from metastatic cancer of the breast but also of prostate cancer patients , 2013, Oncoscience.

[126]  W. Barry,et al.  Predictive value of circulating tumor cells (CTCs) in newly-diagnosed and recurrent ovarian cancer patients. , 2013, Gynecologic oncology.

[127]  L. Zon,et al.  Zebrafish cancer: the state of the art and the path forward , 2013, Nature Reviews Cancer.

[128]  Peter Ulz,et al.  Complex tumor genomes inferred from single circulating tumor cells by array-CGH and next-generation sequencing. , 2013, Cancer research.

[129]  Tim Holland-Letz,et al.  Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay , 2013, Nature Biotechnology.

[130]  Wei Yin,et al.  The Identification and Characterization of Breast Cancer CTCs Competent for Brain Metastasis , 2013, Science Translational Medicine.

[131]  Sridhar Ramaswamy,et al.  Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition , 2013, Science.

[132]  Hans Clevers,et al.  Lineage Tracing Reveals Lgr5+ Stem Cell Activity in Mouse Intestinal Adenomas , 2012, Science.

[133]  C. Begley,et al.  Drug development: Raise standards for preclinical cancer research , 2012, Nature.

[134]  N. Trede,et al.  A model 450 million years in the making: zebrafish and vertebrate immunity , 2012, Disease Models & Mechanisms.

[135]  Joe W. Gray,et al.  HER2 signaling pathway activation and response of breast cancer cells to HER2-targeting agents is dependent strongly on the 3D microenvironment , 2010, Breast Cancer Research and Treatment.

[136]  H. Clevers,et al.  Single Lgr5 stem cells build crypt–villus structures in vitro without a mesenchymal niche , 2009, Nature.

[137]  W. Gerald,et al.  Genes that mediate breast cancer metastasis to the brain , 2009, Nature.

[138]  Sanjay Kumar,et al.  Mechanics, malignancy, and metastasis: The force journey of a tumor cell , 2009, Cancer and Metastasis Reviews.

[139]  Roy A Jensen,et al.  A human breast cell model of preinvasive to invasive transition. , 2008, Cancer research.

[140]  Genee Y. Lee,et al.  Three-dimensional culture models of normal and malignant breast epithelial cells , 2007, Nature Methods.

[141]  H. Kleinman,et al.  Matrigel: basement membrane matrix with biological activity. , 2005, Seminars in cancer biology.

[142]  R. Hruban,et al.  Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. , 2005, Cancer cell.

[143]  D. Wendt,et al.  The role of bioreactors in tissue engineering. , 2004, Trends in biotechnology.

[144]  Robert A. Weinberg,et al.  Creation of human tumour cells with defined genetic elements , 1999, Nature.

[145]  A. Weiss,et al.  Detection and characterization of carcinoma cells in the blood. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[146]  C. Larabell,et al.  Reversion of the Malignant Phenotype of Human Breast Cells in Three-Dimensional Culture and In Vivo by Integrin Blocking Antibodies , 1997, The Journal of cell biology.

[147]  J. Allison,et al.  Enhancement of Antitumor Immunity by CTLA-4 Blockade , 1996, Science.

[148]  M. Bissell,et al.  Interaction with basement membrane serves to rapidly distinguish growth and differentiation pattern of normal and malignant human breast epithelial cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[149]  K. Gärtner,et al.  A third component causing random variability beside environment and genotype. A reason for the limited success of a 30 year long effort to standardize laboratory animals? , 1990, Laboratory animals.

[150]  D. Morton,et al.  Rapid assay for evaluating the chemosensitivity of human tumors in soft agar culture. , 1982, Cancer research.